Whole genome cancer detection

It wasn’t long ago since the genome was fully decoded. Now, Israel’s C2i Genomics (see here previously) has teamed up with Tel Aviv’s Sourasky (Ichilov) Medical Center take blood test data and perform whole genome minimal residual disease (MRD) testing to detect recurring cancer early.



This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *